A Novel Approach of Drug Localization through Development of Polymeric Micellar System Containing Azelastine HCl for Ocular Delivery
- PMID: 31362666
- PMCID: PMC7040519
- DOI: 10.2174/2211738507666190726162000
A Novel Approach of Drug Localization through Development of Polymeric Micellar System Containing Azelastine HCl for Ocular Delivery
Abstract
Background: Development of polymeric micelles for the management of allergic conjunctivitis to overcome the limitations of topical installation, such as poor patient compliance, poor stromal permeability, and significant adverse effects, increase precorneal residence time and efficacy, and also control the release of drug at the target site.
Objective: The investigation was aimed at developing a polymeric micellar system of Azelastine HCl for Ocular Delivery.
Methods: Drug loaded micelles of tri-block copolymers Pf 127 were prepared by Thin Film hydration method. The polymeric micelles formulations (F1 to F9) were assessed for entrapment efficiency, micelle size, in vitro permeation, ex vivo transcorneal permeation, in vivo Ocular Irritation, and Histology.
Results: Optimized micelles formulation (F3), with the lowest micelle size of 92 nm, least polydispersity value of 0.135, highest entrapment efficiency of 95.30 ± 0.17%, and a cumulative drug permeation of 84.12 ± 1.26% in 8h, was selected to develop pH-sensitive micelles loaded carbopol in situ gel. The optimized in situ gel (G4) proved to be superior in its ex vivo transcorneal permeation when compared with Market Preparation and pure drug suspension, exhibiting 43.35 ± 1.48% Permeation with zero-order kinetics (r2 = 0.9944) across goat cornea. Transmission Electron microscopy revealed spherical polymeric micelles trapped in the gel matrix. A series of experiments showed hydration capability, non-irritancy, and histologically safe gel formulation that had appropriate handling characteristics.
Conclusion: A controlled release pH-sensitive ocular formulation capable of carrying the drug to the anterior section of the eye via topical delivery was successfully developed for the treatment of allergic conjunctivitis.
Keywords: Azelastine HCl; entrapment efficiency; ex vivo transcorneal permeation; histology; in vitro permeation; in vivo ocular irritation; transmission electron microscopy; tri-block copolymers..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures






Similar articles
-
Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis.Colloids Surf B Biointerfaces. 2015 Jun 1;130:23-30. doi: 10.1016/j.colsurfb.2015.03.059. Epub 2015 Apr 6. Colloids Surf B Biointerfaces. 2015. PMID: 25889081
-
Polymeric micelles loaded in situ gel with prednisolone acetate for ocular inflammation: development and evaluation.Nanomedicine (Lond). 2023 Aug;18(20):1383-1398. doi: 10.2217/nnm-2023-0123. Epub 2023 Sep 13. Nanomedicine (Lond). 2023. PMID: 37702303
-
Itraconazole Loaded Micelle Based on Methoxy Poly(Ethylene Glycol)-Poly(D, L-Lactic Acid) for Ocular Drug Delivery: In vitro and in vivo Evaluation.Int J Nanomedicine. 2025 May 22;20:6447-6462. doi: 10.2147/IJN.S521127. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40420914 Free PMC article.
-
Role of Polymeric Micelles in Ocular Drug Delivery: An Overview of Decades of Research.Mol Pharm. 2023 Nov 6;20(11):5359-5382. doi: 10.1021/acs.molpharmaceut.3c00598. Epub 2023 Sep 28. Mol Pharm. 2023. PMID: 37769017 Review.
-
Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):323-341. doi: 10.1089/jop.2019.0109. Epub 2020 Apr 20. J Ocul Pharmacol Ther. 2020. PMID: 32310723 Review.
Cited by
-
The Use of Polymer Blends in the Treatment of Ocular Diseases.Pharmaceutics. 2022 Jul 7;14(7):1431. doi: 10.3390/pharmaceutics14071431. Pharmaceutics. 2022. PMID: 35890326 Free PMC article. Review.
-
Considerations for Polymers Used in Ocular Drug Delivery.Front Med (Lausanne). 2022 Jan 28;8:787644. doi: 10.3389/fmed.2021.787644. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155469 Free PMC article. Review.
-
Recent development of polymer nanomicelles in the treatment of eye diseases.Front Bioeng Biotechnol. 2023 Aug 4;11:1246974. doi: 10.3389/fbioe.2023.1246974. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37600322 Free PMC article. Review.
References
-
- Kuno N., Fujii S. Recent advances in ocular drug delivery systems. Polymers (Basel) 2011;3(1):193–221.
-
- Danion A., Arsenault I., Vermette P. Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin. J. Pharm. Sci. 2007;96(9):2350–2363. - PubMed
-
- Short B.G. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol. Pathol. 2008;36(1):49–62. - PubMed
-
- Gulsen D., Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci. 2004;45(7):2342–2347. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous